“Antitumor Activity of New Methylpyrazolotriazine and Pyrazolobenzotriazine Derivatives Tested on MCF-7, MDA-MB-231, and BT-474 Breast Cancer Cell Lines”. 2026. Voprosy Onkologii 72 (3): OF-2446. https://doi.org/10.37469/0507-3758-2026-72-3-OF-2446.